Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for heart rate reduction before elective PCI in stable coronary artery disease
ISRCTN59609019Phase 4Completed
- Sponsor
- University Clinical Centre Maribor
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ivabradine in coronary arteriosclerosis and angina pectoris, sponsored by University Clinical Centre Maribor. Primary endpoint: Periprocedural myocardial injury. Started May 2010; status: completed.
02
Drugs
ivabradine
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on ISRCTN59609019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN59609019.